Author

Yue Feng

Institution: Jiangsu Ocean University

Observed institutions: Shanghai University, China Pharmaceutical University, Jiangsu Ocean University, Shanghai University of Traditional Chinese Medicine, Shuguang Hospital

ORCID: 0000-0003-0795-6139

Observed ORCID: 0000-0003-0795-6139

OpenAlex ID: A5072841491

Efficacy and Safety of Poly (ADP-Ribose) Polymerase Inhibitors in Combination with Chemotherapy for Advanced Breast Cancer: A Systematic Review and Meta-Analysis

2025 · Qiuhua Duan, Yue Feng, et al. · Technology in Cancer Research & Treatment · 3

Efficacy and Safety Analysis of Recombinant Human Endostatin (Endostar) Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer: A 2-Center Retrospective Study

2024 · Yue Feng, Xin Li, et al. · Technology in Cancer Research & Treatment · 3

Effects of the PARP inhibitor Niraparib on the radiosensitivity of human lung and cervical cancer cells

2023 · Yue Feng, Shiyi Pi, et al. · Radiation Medicine and Protection · 3

Region-Specific Metabolic Alterations in the Tryptophan Pathway in Cisplatin-Induced Acute Kidney Injury

2025 · Yue Feng, Ying Zhang, et al. · Chemical Research in Toxicology · 1

Efficacy and Mechanism of Compound Danshen Dripping Pills on Disseminated Intravascular Coagulation Animal Model

2025 · Jing Wang, Yue Feng, et al. · World Journal of Traditional Chinese Medicine · 1

Synthesis, anticancer activity, X-ray crystallography, molecular docking, and molecular dynamics simulation of 4-aminoindazole derivatives

2026 · Zeng-feng Zhang, Chang-gang Song, et al. · Journal of Molecular Structure

Works count: 6

Citation count: 11

H-index: 3

I10-index: